Drug intelligence / Profile preview

calculus bovis + metronidazole

Development stage
Unknown
Lead developer
Shandong Xinhua Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Calculus bovis + metronidazole is a small-molecule combination drug approved in China for the treatment of acute oral and dental infections. It consists of metronidazole, a synthetic nitroimidazole antibiotic, and artificial calculus bovis (Niuhuang), a traditional Chinese medicine ingredient. Metronidazole exerts its antimicrobial effect by entering bacterial cells and forming unstable intermediate metabolites that bind to DNA, causing strand breakage and inhibition of nucleic acid synthesis, specifically targeting anaerobic bacteria. Artificial calculus bovis provides complementary anti-inflammatory, antipyretic, and detoxifying effects, which help alleviate the pain and swelling associated with dental conditions such as wisdom tooth pericoronitis, pulpitis, and alveolar abscesses. The combination is typically formulated as oral capsules.

Other names
Galculus Bovis + MetronidazoleCalculus Bovis plus MetronidazoleArtificial Calculus Bovis and MetronidazoleNiuhuang Metronidazole
02

Targets

dsDNA (Microbial double-stranded DNA)

Beyond the preview

Go deeper on calculus bovis + metronidazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on calculus bovis + metronidazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call